Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $3.53 billion. The enterprise value is $2.92 billion.
| Market Cap | 3.53B |
| Enterprise Value | 2.92B |
Important Dates
The next estimated earnings date is Wednesday, July 22, 2026, after market close.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VKTX has 116.11 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | 116.11M |
| Shares Outstanding | 116.11M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 63.53% |
| Float | 113.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.01 |
| P/TBV Ratio | 7.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.72
| Current Ratio | 5.72 |
| Quick Ratio | 5.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15,687.44 |
Financial Efficiency
Return on equity (ROE) is -70.04% and return on invested capital (ROIC) is -46.49%.
| Return on Equity (ROE) | -70.04% |
| Return on Assets (ROA) | -42.54% |
| Return on Invested Capital (ROIC) | -46.49% |
| Return on Capital Employed (ROCE) | -100.02% |
| Weighted Average Cost of Capital (WACC) | 7.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$8.01M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.95% in the last 52 weeks. The beta is 0.68, so VKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +14.95% |
| 50-Day Moving Average | 31.50 |
| 200-Day Moving Average | 32.41 |
| Relative Strength Index (RSI) | 51.10 |
| Average Volume (20 Days) | 1,977,880 |
Short Selling Information
The latest short interest is 22.37 million, so 19.27% of the outstanding shares have been sold short.
| Short Interest | 22.37M |
| Short Previous Month | 22.28M |
| Short % of Shares Out | 19.27% |
| Short % of Float | 19.75% |
| Short Ratio (days to cover) | 10.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -502.00M |
| Pretax Income | -472.34M |
| Net Income | -472.34M |
| EBITDA | n/a |
| EBIT | -502.00M |
| Earnings Per Share (EPS) | -$4.16 |
Balance Sheet
The company has $602.96 million in cash and n/a in debt, with a net cash position of $602.96 million or $5.19 per share.
| Cash & Cash Equivalents | 602.96M |
| Total Debt | n/a |
| Net Cash | 602.96M |
| Net Cash Per Share | $5.19 |
| Equity (Book Value) | 501.92M |
| Book Value Per Share | 4.33 |
| Working Capital | 501.88M |
Cash Flow
| Operating Cash Flow | -340.33M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 405,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | -13.39% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VKTX is $92.58, which is 204.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $92.58 |
| Price Target Difference | 204.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |